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“Young Women with Pad are at High Risk of Cardiovascular Complications”
E.S. Debus*
University Heart Center, Department for Vascular Medicine, University Clinics of Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, GermanyMost manifestations of cardiovascular disease are more
common inmen than inwomen. However, cardiovascular disease is
the most common cause of death in women worldwide.1 Coronary
heart disease in women has a worse outcome than in men, and
there is increasing evidence, that abdominal aortic aneurysms in
women also are associated with a worse prognosis. At least, for the
latter entity a gaining weight of existing knowledge suggests, that
this should be associated with a more aggressive approach for
elective repair in women than in men.2
Are there gender differences in peripheral arterial disease
(PAD)?
Patients with peripheral arterial disease (PAD) are associated
with a 10 years decreased life expectancy compared to the age-
adjusted healthy population. Additionally, they have greater func-
tional impairments and higher risk of fatal and non-fatal cardio-
vascular events compared with patients with symptomatic
atherosclerosis in other vascular beds such as coronary, carotid and
cerebral arteries.3 The precise assessment of epidemiologic data on
PAD however is almost impossible e for several reasons. Due to
different study designs and deﬁnitions, data often are incoherent;
identiﬁcation of PAD differs depending on ABI deﬁnition,4 and
natural history of PAD does not always follow standardized
progression through different clinical stages.5 Incidence and prev-
alence of PAD vary signiﬁcantly between population based studies
and registries and is depending on population and end points. For
instance, according to the svedvasc registry the prevalence of
critical limb ischemia was estimated to be at least 15.000 patients,
however the number of interventions counted was only 1700
during the period.6 In serial studies the gender ratio between men
and women in PAD was 3:1.7 In contrast, other epidemiological
studies found an equal correlation between men and women in
a long-term course of 50 years.8,9 Wisman and coworkers focus on
this important and still underestimated topic in vascular care.10 By
extrapolating data from the BOA study,11 representing the general
Dutch moderate to severe PAD population, they searched for
gender differences in cardiovascular comorbidity. Although they
did not ﬁnd, that gender itself was an independent risk factor for
cardiovascular complications, women younger than 60 years were
associated with a ﬁve fold higher risk of cardiovascularDOI of original article: 10.1016/j.ejvs.2012.01.006.
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found, that womenwere older and had a more advanced PAD stage
and more often hypertension at the time of intervention than men.
In contrast, more men were smoker, had prior myocardial infarc-
tion and had prior vascular interventions. Different bypass proce-
dures inﬂuenced the sex speciﬁc results, and femorocrural bypass
was an independent risk factor for myocardial infarction and
cardiovascular death in women. Aspirin or anticoagulant treatment
did not inﬂuence the results.
Certainly, the incidence and prevalence of PAD is higher in men
than in women, but the latter are underrepresented in large
epidemiologic studies e as it was demonstrated in the BOA study.
Does this mean, that women are underdiagnosed with respect to
PAD? There are arguments in favour of this hypothesis: women
tend to be older when revascularized than men. And women are
associated with a poorer prognosis than men. So, are we discussing
just an epiphenomenon? Early recognition and diagnosis may lead
to earlier therapy in less advanced stages and e conclusively e to
better outcomes. At least in studies, a higher awareness of gender
differences should be mandatory to get an unbiased picture on
their results. The authors of this study however stressed a number
of possible confounders, possibly explaining gender differences,
such as estrogen, diabetes, smoking habits and others. However,
a conclusive explanation for this is impossible, due to small
numbers and series. Therefore, conclusive explanations for gender
differences are still open.
Although the authors focus on an important issue, this study has
a number of limitations. It seems, that there was a difﬁculty in
obtaining clean information about follow up among the enrolled
patients of this study. A variety of different forms for collecting
information was used, from data obtained by general practitioners
to data directly obtained by relatives or acquaintances. There might
be a discrepancy among data obtained from different sources of
information. Furthermore, a recall bias might have been occurred
regarding information obtained from relatives. The BOA study was
initially designed for studying the effects of oral anticoagulants and
aspirin in preventing bypass occlusion as primary end point.
However, the study was not designed for detecting gender differ-
ences in cardiovascular risk factors in a PAD population. Only six of
the initially including study centers were included for long-term
follow up (n ¼ 18%). Obviously, interpretation from this longitu-
dinal cohort study has its limitations. Anyhow, Doctor Wisman and
coworkers should be congratulated for putting the focus on this
important issue in vascular care e which is still largely under-ed by Elsevier Ltd. All rights reserved.
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research. To get more detailed and more reliable insights in gender
differences with possible implementations on different treatment
options, studies with speciﬁc focus on this question should be
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